These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2148048)

  • 41. The gene for the human immune interferon receptor is located on chromosome 6.
    Rashidbaigi A; Langer JA; Jung V; Jones C; Morse HG; Tischfield JA; Trill JJ; Kung HF; Pestka S
    Proc Natl Acad Sci U S A; 1986 Jan; 83(2):384-8. PubMed ID: 2934742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of 32P-labeled murine immune interferon and its binding to the mouse immune interferon receptor.
    Langer JA; Rashidbaigi A; Pestka S
    J Biol Chem; 1986 Jul; 261(21):9801-4. PubMed ID: 3015908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble cytokine receptors are present in normal human urine.
    Novick D; Engelmann H; Wallach D; Rubinstein M
    J Exp Med; 1989 Oct; 170(4):1409-14. PubMed ID: 2529343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of 32P-labeled human recombinant immune interferon to U937 cells.
    Rashidbaigi A; Kung HF; Pestka S
    Methods Enzymol; 1986; 119():315-21. PubMed ID: 2945073
    [No Abstract]   [Full Text] [Related]  

  • 45. Investigation of an antibody reported to identify leukocyte immunoglobulin-like receptors (LILRB2) on placental vascular smooth muscle.
    Hunt JS; Clavellina CV
    Placenta; 2010 Mar; 31(3):249-50. PubMed ID: 19913297
    [No Abstract]   [Full Text] [Related]  

  • 46. Demonstration and partial characterization of the interferon-gamma receptor on human B lymphocytes.
    Nakagawa T; Nakagawa N; Delsing GA; Volkman D; Kehrl JH
    J Cell Biochem; 1989 Aug; 40(4):417-30. PubMed ID: 2528554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitation and characterization of gamma-interferon receptors on human tumor cells.
    Ucer U; Bartsch H; Scheurich P; Berkovic D; Ertel C; Pfizenmaier K
    Cancer Res; 1986 Oct; 46(10):5339-43. PubMed ID: 2944578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.
    Sheehan KC; Calderon J; Schreiber RD
    J Immunol; 1988 Jun; 140(12):4231-7. PubMed ID: 2453573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A convenient assay for detection of soluble interferon receptors.
    Stefanos S; Pestka S
    J Biol Regul Homeost Agents; 1990; 4(2):57-9. PubMed ID: 2148048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of functional type I and type II interferon receptors.
    Pestka S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interferon gamma receptor.
    Celada A
    Lymphokine Res; 1988; 7(1):61-73. PubMed ID: 2966266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The human interferon-gamma receptor system.
    Rubinstein M; Novick D; Fischer DG
    Immunol Rev; 1987 Jun; 97():29-50. PubMed ID: 2957306
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.